[몰누피라비르 관련 표준물질/Molnupiravir Compound] Molnupiravir helps in faster recovery of mild covid patients - SimSon Pharma Limited 수입/공급 전문 코아사이언스

안녕하세요!

연구용 시약 및 표준품(표준물질) 전문제조사 SimSon Pharma Limited 공식 수입/공급 업체 코아사이언스 입니다.

 

자세한 상품 정보 및 관련 문의는 전화 02-858-0328 또는 info@coresciences.co.kr로 문의주시기 바랍니다.

감사합니다!

New drug Molnupiravir helps in faster recovery of mild covid patients

Molnupiravir the drug — an oral antiviral — when administered to mild Covid patients, helped them recover faster, in comparison to those who received standard of care (SOC, the treatment process followed by a doctor based on the patient’s requirements, illness and clinical circumstances) treatment alone.

The drug is a potent ribonucleoside analog (known to block RNA viruses associated with influenza-like diseases) that inhibits the replication of multiple RNA viruses (those that have ribonucleic acid as its genetic material), including SARS-CoV-2, the causative agent of Covid.

코아사이언스 coresciences​ SimSon Pharma 수입 한국 표준품 표준물질 유연물질 reference material chemicals reference substances APIs impurity impurities working standards reference standards